Company / Cost of Revenue
ICU Medical Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.4B
FY2025
5-year range
$794.3M / $1.6B
FY2021-FY2025
Trend
-9.5%
vs FY2024
Sector context
#39 of 113
Health Care
What the data says
At $1.4B, ICU Medical's cost of revenue ranks #75 of 113 in the Health Care sector. Cost of Revenue has fluctuated over the past 10 years, ranging from $158M in FY2016 to $1.6B in FY2024.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +11.2%.
Improved from $1.5B to $1.4B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +20.3%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
#75 of 113 in Health CareTop 65% of 113This company $1.4B Sector average $11.3B
▼
-87.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.2%, indicating consistent growth.
- In FY2025, cost of revenue decreased 9.5% year-over-year.
- Ranks #39 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | -9.5% |
| FY2024 | $1.6B | +2.5% |
| FY2023 | $1.5B | +87.7% |
| FY2022 | $809.5M | +1.9% |
| FY2021 | $794.3M | -4.3% |
| FY2020 | $830.0M | -4.2% |
| FY2019 | $866.5M | +386.9% |
| FY2018 | $178.0M | +10.6% |
| FY2017 | $160.9M | +1.9% |
| FY2016 | $157.9M | -0.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026